Coordinated Sentinel Surveillance and Discovery for Emerging Human Pathogens

The Centers for Disease Control and Prevention is forecasting a contract titled Coordinated Sentinel Surveillance and Discovery for Emerging Human Pathogens, set to be posted on May 25, 2026, under NAICS code 541712, which covers research and development in the physical, engineering, and life sciences. The primary objective is to establish a coordinated network for early detection and characterization of emerging human pathogens through sentinel surveillance systems and advanced discovery methods. This initiative aims to strengthen national capabilities in identifying novel infectious agents before they escalate into widespread public health threats, leveraging real-time data collection, genomic sequencing, and analytical tools across diverse geographic and demographic settings. The program will rely on collaboration with healthcare facilities, laboratories, and public health agencies to ensure rapid response and data sharing. The point of contact for this opportunity is Latoshia Gray, serving as the Program Point of Contact, with the contracting officer position listed as to be determined. All communications and submissions should be directed to lqg8@cdc.gov. The place of performance and specific location details have not been designated, indicating flexibility in geographic scope to support a nationwide or multi-region surveillance infrastructure. This forecast signals CDC’s intent to invest in proactive pathogen monitoring systems that integrate clinical, environmental, and genomic data streams to enhance readiness for future outbreaks. While no set-aside provisions are specified, the solicitation is expected to attract qualified research organizations, academic institutions, and private sector entities with expertise in infectious disease surveillance, bioinformatics, and public health diagnostics.